Researchers analyzed patient data from the Alzheimer’s Disease in Down Syndrome study to determine the sex differences in Alzheimer-related neuropsychiatric symptomology among adults with Down syndrome. ...
Using data from the National Alzheimer’s Coordinating Center, a team of researchers investigated any correlations between neuropsychiatric and depressive symptoms at AD dementia diagnosis. Their findings...
Researchers set out to determine whether attention-deficit/hyperactivity disorder predisposes individuals to the development of neuropsychiatric symptoms. The researchers presented their findings at the...
Researchers sought to determine the efficacy of brexpiprazole in reducing agitation symptoms in patients with dementia due to Alzheimer disease. The results were presented at the Alzheimer Association...
Researchers evaluated the association between neuropsychiatric symptoms, such as agitation and apathy, in patients with Alzheimer disease and the rate of functional decline.
Researchers used data from the Alzheimer's Disease Neuroimaging Initiative database to identify specific brain regions associated with hyperactive neuropsychiatric symptoms among patients with mild...
Researchers examining patients with late-stage dementia and significant agitation, found that a wearable device such as a wrist-worn actigraphy could be a feasible behavior-monitoring tool to assess sleep...
Researchers compared clinical characteristics, health care costs, and mortality outcomes among patients with Alzheimer dementia with and without agitation.
Researchers evaluated the safety and efficacy of dextromethorphan-bupropion, an FDA approved treatment of major depression disorder, for Alzheimer disease-related agitation. This study was presented at the...
Researchers collected data from the Atherosclerosis Risk in Communities Study to determine whether heart rate variability was associated with agitation risk in individuals clinically diagnosed with dementia...
